Dergiler / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 2

Roles of angiotensin II, Olmesartan and PD123319 on proliferation, oxidative stress and TGF-β1 in HUVEC culture

Sayfa
136–143
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: Ang II shows its proliferative effects through ATR1 activation, whereas stimulation of ATR2 seems to have a key role in the pathophysiology of oxidative stress.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Angiotensin II (Ang II) causes endothelial cell damage.
📊
Temel Bulgular & Veri:Oxidative stress is involved in the pathophysiology of cardiovascular diseases via transforming growth factor-beta 1 (TGF-β1).
💡
Sonuç & Katkı:Conclusions: Ang II shows its proliferative effects through ATR1 activation, whereas stimulation of ATR2 seems to have a key role in the pathophysiology of oxidative stress.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aims: Angiotensin II (Ang II) causes endothelial cell damage. Oxidative stress is involved in the pathophysiology of cardiovascular diseases via transforming growth factor-beta 1 (TGF-β1). In most studies increases in Ang II and TGF-β1 levels in several cell types are bidirectional. The present study investigated the effects of Ang II on oxidative stress, cell proliferation, and TGF-β1 levels in human umbilical vein endothelial cells (HUVECs). Methods: HUVECs were treated with Ang II (0.1 µM), Ang II type 1 receptor (ATR1) antagonist Olmesartan (1 µM), and Ang II type 2 receptors (ATR2) antagonist PD123319 (1 µM) for 24 hours. Cell proliferation and viability were evaluated by the tetrazolium salt (MTT) assay. Total antioxidant capacity (TAC) and total oxidant capacity (TOC) were measured by spectrophotometer intracellularly and in the culture medium. The TGF-β1 level was measured by enzyme-linked immunosorbent assay (ELISA). Results: The addition of 1 µM, 0.1 µM, and 0.01 µM Ang II increased proliferation in HUVECs. Cell proliferation increased significantly in both Ang II and Ang II+Olmesartan+PD123319 groups. However, Ang II+Olmesartan tended to decrease cell proliferation. In the control group TAC and TOC levels remained in the normal range in HUVEC extracts. In other all groups, TOC values increased compared to control. In HUVECs medium, TAC level was higher in the control, Ang II and Ang II+Olmesartan groups, but normal and tolerable in other groups whereas, TOC levels were elevated in control and other all groups. In HUVECs extracts, compared with the control, TGF-β1 level was significantly lower in the Ang II group, but increased in the Ang II+Olmesartan group. There was no significant difference in TGF-β1 levels between medium groups. Conclusions: Ang II shows its proliferative effects through ATR1 activation, whereas stimulation of ATR2 seems to have a key role in the pathophysiology of oxidative stress.

🔖

Bu Makaleye Atıf Yap

AKILLIOĞLU, K., ÇİÇEK, Z., İLHAN, A. Ş. (2022). Roles of angiotensin II, Olmesartan and PD123319 on proliferation, oxidative stress and TGF-β1 in HUVEC culture. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 2, 136–143. https://ajindex.com/articles/526764

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Galley HF, Webster NR. Physiology of the endothelium. British Journal of Anaesthesia. 2004;93:105-113
  2. Du J, Leng J, Zhang L, Bai G, Yang D, Lin H, et al. Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was Inhibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways. Med Sci Monit. 2016;22:3223-3228
  3. Bierhansl L, Conradi LC, Treps L, Dewerchin M, Carmeliet P. Central Role of Metabolism in Endothelial Cell Function and Vascular Disease. Physiology. 2017;32:126-140
  4. Medina-Leyte DJ, Dominguez-Perez M, Mercado I, VillarrealMolina MT, Jacobo-Albavera L. Use of Human Umbilical Vein Endothelial Cells (HUVEC) as a Model to Study Cardiovascular Disease: A Review. Appl Sci-Basel. 2020;10
  5. Xu J, Shi GP. Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta. 2014;1842:2106- 2119
  6. Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 Suppl B):9-20
  7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol-Cell Ph. 2007;292:C82-C97
  8. Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev. 2018;98:1627-1738
  9. Wang M, Liu Y, Liang Y, Naruse K, Takahashi K. Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions-Diabetes Mellitus, Cardiovascular Diseases, and Ischemia-Reperfusion Injury. Front Cardiovasc Med. 2021;8:649785
  10. Sena CM, Leandro A, Azul L, Seica R, Perry G. Vascular Oxidative Stress: Impact and Therapeutic Approaches. Front Physiol. 2018;9:1668
  11. Phaniendra A, Jestadi DB, Periyasamy L. Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases. Indian J Clin Bioche. 2015;30:11-26
  12. Munzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of Oxidative Stress on the Heart and Vasculature Part 2 of a 3-Part Series. J Am Coll Cardiol. 201711;70:212- 229
  13. Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977-2992
  14. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A. Transforming growth factor-beta. Cancer Surveys. 1992;12:81-103
  15. Tian M, Schiemann WP. The TGF-beta paradox in